Clinical Trial Update: Melatonin in Relapsing-Remitting Multiple Sclerosis Patients [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating melatonin in relapsing-remitting multiple sclerosis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Relapsing-remitting Multiple Sclerosis

Drugs mentioned

• Melatonin (melatonin)

Snippet

Sponsor: Tehran University of Medical Sciences | Conditions: Multiple Sclerosis, Relapsing-Remitting | Phase 2 | Status: COMPLETED